Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Traceless solid-phase synthesis of bicyclic dihydropyrimidones using multidirectional cyclization cleavage.

Rolando Pérez1, Tetyana Beryozkina, Oleksandr I Zbruyev

  • 1Institute of Chemistry, Karl-Franzens-University Graz, Heinrichstrasse 28, A-8010 Graz, Austria.

Journal of Combinatorial Chemistry
|September 10, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same author

Aberrant chromatin remodeling influences human neural cell fate change in Trisomy 21.

bioRxiv : the preprint server for biology·2026
Same author

An orally active dual CBP/p300 degrader targets core dependencies of multiple myeloma.

Cell reports·2026
Same author

Mastering the potential of well-defined ML<sup>1</sup>L<sup>2</sup> species in asymmetric catalysis through ligand immobilization (ML<sup>het</sup>L<sup>hom</sup>). Use in highly enantioselective Pd-catalyzed spiroannulation.

Chemical science·2026
Same author

Automated Dynamic Flow Experimentation for Rapid Kinetic Fitting of Transition Metal Catalysis.

Angewandte Chemie (International ed. in English)·2026
Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026

This study reports novel solid-phase synthesis methods for furo[3,4-d]pyrimidines, pyrrolo[3,4-d]pyrimidines, and pyrimido[4,5-d]pyridazines. These efficient protocols utilize microwave technology for rapid scaffold generation with good yields.

Area of Science:

  • Organic Chemistry
  • Medicinal Chemistry
  • Synthetic Chemistry

Background:

  • Heterocyclic compounds are crucial scaffolds in medicinal chemistry.
  • Developing efficient and versatile synthetic routes is essential for drug discovery.
  • Solid-phase synthesis offers advantages in purification and automation.

Purpose of the Study:

  • To develop novel solid-phase and solution-phase protocols for synthesizing furo[3,4-d]pyrimidines, pyrrolo[3,4-d]pyrimidines, and pyrimido[4,5-d]pyridazines.
  • To establish a common chemical platform for generating diverse heterobicyclic scaffolds.
  • To explore traceless cyclative cleavage strategies for efficient compound release.

Main Methods:

  • Microwave-promoted acetoacetylation of hydroxymethylpolystyrene resin.

Related Experiment Videos

  • Three-component Biginelli-type condensations on solid support.
  • Three distinct traceless cyclative cleavage strategies (thermal, nucleophilic with amines, nucleophilic with hydrazines).

    • Main Results:

    • Successful synthesis of furo[3,4-d]pyrimidines via thermal cyclative release.
    • Generation of pyrrolo[3,4-d]pyrimidine scaffolds through nucleophilic cyclative cleavage with primary amines.
    • Formation of pyrimido[4,5-d]pyridazines by reaction with monosubstituted hydrazines.
    • Compounds obtained in moderate to good overall yields and purities.

    Conclusions:

    • The developed solid-phase protocols provide a versatile and efficient method for accessing diverse heterobicyclic compounds.
    • Microwave-assisted synthesis accelerates reaction times and improves efficiency.
    • The common resin-bound dihydropyrimidone platform allows for modular synthesis of multiple heterocyclic systems.